RhumbLine Advisers’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1
| Closed | -$3 | – | 4269 |
|
|
2023
Q3 | $3 | Sell |
1
-21
| -95% | -$63 | ﹤0.01% | 4303 |
|
|
2023
Q2 | $94 | Buy |
+22
| New | +$94 | ﹤0.01% | 4367 |
|
|
2021
Q2 | – | Sell |
-1,708
| Closed | -$95K | – | 3018 |
|
|
2021
Q1 | $95K | Buy |
1,708
+5
| +0.3% | +$278 | ﹤0.01% | 2940 |
|
|
2020
Q4 | $104K | Buy |
1,703
+232
| +16% | +$14.2K | ﹤0.01% | 2965 |
|
|
2020
Q3 | $179K | Sell |
1,471
-234
| -14% | -$28.5K | ﹤0.01% | 2720 |
|
|
2020
Q2 | $202K | Buy |
1,705
+388
| +29% | +$46K | ﹤0.01% | 2767 |
|
|
2020
Q1 | $70K | Hold |
1,317
| – | – | ﹤0.01% | 2834 |
|
|
2019
Q4 | $72K | Buy |
1,317
+16
| +1% | +$875 | ﹤0.01% | 2901 |
|
|
2019
Q3 | $315K | Buy |
1,301
+15
| +1% | +$3.63K | ﹤0.01% | 2555 |
|
|
2019
Q2 | $295K | Buy |
+1,286
| New | +$295K | ﹤0.01% | 2614 |
|